Industry Research Reports

Home > Reports > Medical Care > Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Care

Published Date: 2026-07-18

Pages: 153 Pages

Report ld: 5779246

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Adeno-Associated Virus (AAV) Packaging Service Market Size(US$)

CAGR 2026-2032

11.1%

Market Size,2032

USD 2,627

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,397 million

Market Forecast in 2032(Value)

US$ 2,627 million

CAGR

11.1%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1249 million in 2025 and is projected to reach US$ 2627 million, growing at a CAGR of 11.1% from 2026 to 2032.

Adeno-associated virus (AAV) packaging services refer to customized development and manufacturing activities in which a customer-provided or jointly designed ITR-containing construct is packaged into a recombinant AAV vector carrying a gene of interest, gene-silencing sequence, gene-editing component or reporter gene. The service workflow generally includes vector design and construction, plasmid preparation, cell culture and transfection, vector harvest, purification, concentration, aliquoting and quality testing, covering research-grade, preclinical-grade and GMP-grade projects. Key upstream inputs include transfer plasmids, Rep/Cap plasmids, helper plasmids, HEK293 or Sf9 cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables and analytical reagents. Major downstream customers include universities, research institutes, hospital research platforms, gene therapy developers, biotechnology companies, pharmaceutical companies and CROs, with applications spanning basic research, animal studies, preclinical evaluation, IND submissions, clinical development and commercial manufacturing. The industry's overall gross margin is generally estimated at approximately 32%-48%.

The global market consists of research-grade packaging providers, specialized AAV CROs, integrated cell and gene therapy CDMOs and large biopharmaceutical service groups operating dedicated AAV platforms. Research-grade projects are numerous, relatively short and fragmented, with competition centered on serotype coverage, titer, purity, turnaround time and price. Preclinical and GMP programs are less frequent but require considerably greater investment in process scale-up, analytical methods, batch consistency, quality systems and regulatory documentation. Providers capable of maintaining process continuity from vector design and small-scale packaging through GMP and commercial manufacturing generally develop stronger customer retention, particularly after a program enters clinical development.

Demand is supported by gene-function research, rare-disease and neurological gene therapy, engineered-capsid screening, gene-editing delivery and greater outsourcing by biotechnology companies. Different AAV capsids enable gene delivery to the eye, liver, central nervous system, muscle and other tissues, while dual- and multi-vector systems extend the technology to larger or more complex payloads. The FDA's 2026 approval of the first dual-AAV gene therapy for inherited hearing loss demonstrates the continued expansion of AAV into new vector configurations and therapeutic areas, supporting demand for dual-vector development, analytics and scalable manufacturing.

Adherent HEK293 triple-plasmid transfection remains widely used for research and smaller programs, while suspension HEK293 systems have become the principal route for clinical and commercial scale-up. Baculovirus-Sf9 systems are used in selected large-scale processes. Stable producer-cell lines, dual-plasmid systems and plasmid-reduced technologies are being developed to lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward full-capsid enrichment, genome-integrity control and tighter reduction of host-cell proteins, residual DNA, residual plasmids and replication-competent AAV.

The principal constraints include gene therapy financing and pipeline reprioritization, high clinical attrition, underutilized GMP facilities, elevated manufacturing costs and the immunological and safety limitations of AAV. Serious liver-related safety events led the FDA to restrict the use of a major AAV gene therapy in 2025, increasing the focus on dose selection, impurity control, clinical monitoring and long-term follow-up. At the same time, the FDA introduced a more flexible approach to certain cell and gene therapy CMC requirements in 2026, which may help selected rare-disease programs progress more efficiently but does not reduce expectations for identity, potency, purity and manufacturing consistency.

This report provides a comprehensive view of the global market for Adeno-Associated Virus (AAV) Packaging Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Adeno-Associated Virus (AAV) Packaging Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus (AAV) Packaging Service.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific
Lonza
Charles River Laboratories
Catalent
AGC Biologics
SK pharmteco
OXB
Forge Biologics
Viralgen
Andelyn Biosciences
Revvity
Virovek
Fortis Life Sciences
SignaGen Laboratories
Applied Biological Materials
Takara Bio
VectorBuilder
GenScript ProBio
PackGene Biotech
OBiO Technology
Porton Advanced
HanBio

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Research Grade
Preclinical Grade
GMP Grade

Segment by Application

Academic and Research Institutions
Biotechnology Companies
Other

Segment by Category

Packaging Only
Vector Construction and Packaging
End-to-End Development and Manufacturing

Segment by Division

Adherent HEK293
Suspension HEK293
Baculovirus-Sf9
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Adeno-Associated Virus (AAV) Packaging Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Adeno-Associated Virus (AAV) Packaging Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Adeno-Associated Virus (AAV) Packaging Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Adeno-Associated Virus (AAV) Packaging Service Product Introduction

1.2 Global Adeno-Associated Virus (AAV) Packaging Service Market Size Forecast (2021–2032)

1.3 Adeno-Associated Virus (AAV) Packaging Service Market Trends & Drivers

1.3.1 Adeno-Associated Virus (AAV) Packaging Service Industry Trends

1.3.2 Adeno-Associated Virus (AAV) Packaging Service Market Drivers & Opportunities

1.3.3 Adeno-Associated Virus (AAV) Packaging Service Market Challenges

1.3.4 Adeno-Associated Virus (AAV) Packaging Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Adeno-Associated Virus (AAV) Packaging Service Players Revenue Ranking (2025)

2.2 Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Adeno-Associated Virus (AAV) Packaging Service Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Adeno-Associated Virus (AAV) Packaging Service

2.6 Adeno-Associated Virus (AAV) Packaging Service Market Competitive Analysis

2.6.1 Adeno-Associated Virus (AAV) Packaging Service Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Adeno-Associated Virus (AAV) Packaging Service Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adeno-Associated Virus (AAV) Packaging Service revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Adeno-Associated Virus (AAV) Packaging Service Market Classification

3.1 Introduction by Type

3.1.1 Research Grade

3.1.2 Preclinical Grade

3.1.3 GMP Grade

3.1.4 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type

3.1.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value, by Type (2021–2032)

3.1.4.3 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value, by Type (%), 2021–2032

3.2 Introduction by Service Scope

3.2.1 Packaging Only

3.2.2 Vector Construction and Packaging

3.2.3 End-to-End Development and Manufacturing

3.2.4 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Service Scope

3.2.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Service Scope (2021 vs 2025 vs 2032)

3.2.4.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value, by Service Scope (2021–2032)

3.2.4.3 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value, by Service Scope (%), 2021–2032

3.3 Introduction by Production Platform

3.3.1 Adherent HEK293

3.3.2 Suspension HEK293

3.3.3 Baculovirus-Sf9

3.3.4 Other

3.3.5 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Production Platform

3.3.5.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Production Platform (2021 vs 2025 vs 2032)

3.3.5.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value, by Production Platform (2021–2032)

3.3.5.3 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value, by Production Platform (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Academic and Research Institutions

4.1.2 Biotechnology Companies

4.1.3 Other

4.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application

4.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (2021–2032)

4.2.3 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region

5.1.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (2021–2026)

5.1.3 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (2027–2032)

5.1.4 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

5.2.2 North America Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

5.3.2 Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

5.4.2 Asia Pacific Adeno-Associated Virus (AAV) Packaging Service Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

5.5.2 South America Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

5.6.2 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.3 United States

6.3.1 United States Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.3.2 United States Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.4.2 Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.5.2 China Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

6.5.3 China Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.6.2 Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.7.2 South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.8.2 Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021–2032

6.9.2 India Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

6.9.3 India Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Thermo Fisher Scientific

7.1.1 Thermo Fisher Scientific Profile

7.1.2 Thermo Fisher Scientific Main Business

7.1.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.1.4 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.1.5 Thermo Fisher Scientific Recent Developments

7.2 Lonza

7.2.1 Lonza Profile

7.2.2 Lonza Main Business

7.2.3 Lonza Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.2.4 Lonza Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.2.5 Lonza Recent Developments

7.3 Charles River Laboratories

7.3.1 Charles River Laboratories Profile

7.3.2 Charles River Laboratories Main Business

7.3.3 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.3.4 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.3.5 Charles River Laboratories Recent Developments

7.4 Catalent

7.4.1 Catalent Profile

7.4.2 Catalent Main Business

7.4.3 Catalent Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.4.4 Catalent Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.4.5 Catalent Recent Developments

7.5 AGC Biologics

7.5.1 AGC Biologics Profile

7.5.2 AGC Biologics Main Business

7.5.3 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.5.4 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.5.5 AGC Biologics Recent Developments

7.6 SK pharmteco

7.6.1 SK pharmteco Profile

7.6.2 SK pharmteco Main Business

7.6.3 SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.6.4 SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.6.5 SK pharmteco Recent Developments

7.7 OXB

7.7.1 OXB Profile

7.7.2 OXB Main Business

7.7.3 OXB Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.7.4 OXB Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.7.5 OXB Recent Developments

7.8 Forge Biologics

7.8.1 Forge Biologics Profile

7.8.2 Forge Biologics Main Business

7.8.3 Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.8.4 Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.8.5 Forge Biologics Recent Developments

7.9 Viralgen

7.9.1 Viralgen Profile

7.9.2 Viralgen Main Business

7.9.3 Viralgen Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.9.4 Viralgen Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.9.5 Viralgen Recent Developments

7.10 Andelyn Biosciences

7.10.1 Andelyn Biosciences Profile

7.10.2 Andelyn Biosciences Main Business

7.10.3 Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.10.4 Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.10.5 Andelyn Biosciences Recent Developments

7.11 Revvity

7.11.1 Revvity Profile

7.11.2 Revvity Main Business

7.11.3 Revvity Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.11.4 Revvity Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.11.5 Revvity Recent Developments

7.12 Virovek

7.12.1 Virovek Profile

7.12.2 Virovek Main Business

7.12.3 Virovek Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.12.4 Virovek Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.12.5 Virovek Recent Developments

7.13 Fortis Life Sciences

7.13.1 Fortis Life Sciences Profile

7.13.2 Fortis Life Sciences Main Business

7.13.3 Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.13.4 Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.13.5 Fortis Life Sciences Recent Developments

7.14 SignaGen Laboratories

7.14.1 SignaGen Laboratories Profile

7.14.2 SignaGen Laboratories Main Business

7.14.3 SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.14.4 SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.14.5 SignaGen Laboratories Recent Developments

7.15 Applied Biological Materials

7.15.1 Applied Biological Materials Profile

7.15.2 Applied Biological Materials Main Business

7.15.3 Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.15.4 Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.15.5 Applied Biological Materials Recent Developments

7.16 Takara Bio

7.16.1 Takara Bio Profile

7.16.2 Takara Bio Main Business

7.16.3 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.16.4 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.16.5 Takara Bio Recent Developments

7.17 VectorBuilder

7.17.1 VectorBuilder Profile

7.17.2 VectorBuilder Main Business

7.17.3 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.17.4 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.17.5 VectorBuilder Recent Developments

7.18 GenScript ProBio

7.18.1 GenScript ProBio Profile

7.18.2 GenScript ProBio Main Business

7.18.3 GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.18.4 GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.18.5 GenScript ProBio Recent Developments

7.19 PackGene Biotech

7.19.1 PackGene Biotech Profile

7.19.2 PackGene Biotech Main Business

7.19.3 PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.19.4 PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.19.5 PackGene Biotech Recent Developments

7.20 OBiO Technology

7.20.1 OBiO Technology Profile

7.20.2 OBiO Technology Main Business

7.20.3 OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.20.4 OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.20.5 OBiO Technology Recent Developments

7.21 Porton Advanced

7.21.1 Porton Advanced Profile

7.21.2 Porton Advanced Main Business

7.21.3 Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.21.4 Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.21.5 Porton Advanced Recent Developments

7.22 HanBio

7.22.1 HanBio Profile

7.22.2 HanBio Main Business

7.22.3 HanBio Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

7.22.4 HanBio Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021–2026

7.22.5 HanBio Recent Developments

8 Industry Chain Analysis

8.1 Adeno-Associated Virus (AAV) Packaging Service Value Chain

8.2 Adeno-Associated Virus (AAV) Packaging Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Adeno-Associated Virus (AAV) Packaging Service Sales Model

8.5.2 Sales Channels

8.5.3 Adeno-Associated Virus (AAV) Packaging Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Adeno-Associated Virus (AAV) Packaging Service Market Trends

Table 2. Adeno-Associated Virus (AAV) Packaging Service Market Drivers & Opportunities

Table 3. Adeno-Associated Virus (AAV) Packaging Service Market Challenges

Table 4. Adeno-Associated Virus (AAV) Packaging Service Market Restraints

Table 5. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (US$ Million), 2021–2026

Table 6. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Adeno-Associated Virus (AAV) Packaging Service Product Type

Table 9. Key Companies General Availability (GA) Timeline for Adeno-Associated Virus (AAV) Packaging Service

Table 10. Global Adeno-Associated Virus (AAV) Packaging Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adeno-Associated Virus (AAV) Packaging Service revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Type (2021–2026)

Table 17. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Type (2027–2032)

Table 18. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Service Scope: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Service Scope (US$ Million), 2021–2026

Table 20. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Service Scope (US$ Million), 2027–2032

Table 21. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Service Scope (2021–2026)

Table 22. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Service Scope (2027–2032)

Table 23. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Production Platform: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Production Platform (US$ Million), 2021–2026

Table 25. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Production Platform (US$ Million), 2027–2032

Table 26. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Production Platform (2021–2026)

Table 27. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Production Platform (2027–2032)

Table 28. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Application (2021–2026)

Table 32. Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Share in Value by Application (2027–2032)

Table 33. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (%), 2021–2026

Table 37. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Adeno-Associated Virus (AAV) Packaging Service Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Adeno-Associated Virus (AAV) Packaging Service Sales Value, (US$ Million), 2027–2032

Table 41. Thermo Fisher Scientific Basic Information List

Table 42. Thermo Fisher Scientific Description and Business Overview

Table 43. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Thermo Fisher Scientific (2021–2026)

Table 45. Thermo Fisher Scientific Recent Developments

Table 46. Lonza Basic Information List

Table 47. Lonza Description and Business Overview

Table 48. Lonza Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Lonza (2021–2026)

Table 50. Lonza Recent Developments

Table 51. Charles River Laboratories Basic Information List

Table 52. Charles River Laboratories Description and Business Overview

Table 53. Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Charles River Laboratories (2021–2026)

Table 55. Charles River Laboratories Recent Developments

Table 56. Catalent Basic Information List

Table 57. Catalent Description and Business Overview

Table 58. Catalent Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Catalent (2021–2026)

Table 60. Catalent Recent Developments

Table 61. AGC Biologics Basic Information List

Table 62. AGC Biologics Description and Business Overview

Table 63. AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of AGC Biologics (2021–2026)

Table 65. AGC Biologics Recent Developments

Table 66. SK pharmteco Basic Information List

Table 67. SK pharmteco Description and Business Overview

Table 68. SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of SK pharmteco (2021–2026)

Table 70. SK pharmteco Recent Developments

Table 71. OXB Basic Information List

Table 72. OXB Description and Business Overview

Table 73. OXB Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of OXB (2021–2026)

Table 75. OXB Recent Developments

Table 76. Forge Biologics Basic Information List

Table 77. Forge Biologics Description and Business Overview

Table 78. Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Forge Biologics (2021–2026)

Table 80. Forge Biologics Recent Developments

Table 81. Viralgen Basic Information List

Table 82. Viralgen Description and Business Overview

Table 83. Viralgen Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Viralgen (2021–2026)

Table 85. Viralgen Recent Developments

Table 86. Andelyn Biosciences Basic Information List

Table 87. Andelyn Biosciences Description and Business Overview

Table 88. Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Andelyn Biosciences (2021–2026)

Table 90. Andelyn Biosciences Recent Developments

Table 91. Revvity Basic Information List

Table 92. Revvity Description and Business Overview

Table 93. Revvity Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Revvity (2021–2026)

Table 95. Revvity Recent Developments

Table 96. Virovek Basic Information List

Table 97. Virovek Description and Business Overview

Table 98. Virovek Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Virovek (2021–2026)

Table 100. Virovek Recent Developments

Table 101. Fortis Life Sciences Basic Information List

Table 102. Fortis Life Sciences Description and Business Overview

Table 103. Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Fortis Life Sciences (2021–2026)

Table 105. Fortis Life Sciences Recent Developments

Table 106. SignaGen Laboratories Basic Information List

Table 107. SignaGen Laboratories Description and Business Overview

Table 108. SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of SignaGen Laboratories (2021–2026)

Table 110. SignaGen Laboratories Recent Developments

Table 111. Applied Biological Materials Basic Information List

Table 112. Applied Biological Materials Description and Business Overview

Table 113. Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Applied Biological Materials (2021–2026)

Table 115. Applied Biological Materials Recent Developments

Table 116. Takara Bio Basic Information List

Table 117. Takara Bio Description and Business Overview

Table 118. Takara Bio Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Takara Bio (2021–2026)

Table 120. Takara Bio Recent Developments

Table 121. VectorBuilder Basic Information List

Table 122. VectorBuilder Description and Business Overview

Table 123. VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of VectorBuilder (2021–2026)

Table 125. VectorBuilder Recent Developments

Table 126. GenScript ProBio Basic Information List

Table 127. GenScript ProBio Description and Business Overview

Table 128. GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of GenScript ProBio (2021–2026)

Table 130. GenScript ProBio Recent Developments

Table 131. PackGene Biotech Basic Information List

Table 132. PackGene Biotech Description and Business Overview

Table 133. PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of PackGene Biotech (2021–2026)

Table 135. PackGene Biotech Recent Developments

Table 136. OBiO Technology Basic Information List

Table 137. OBiO Technology Description and Business Overview

Table 138. OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of OBiO Technology (2021–2026)

Table 140. OBiO Technology Recent Developments

Table 141. Porton Advanced Basic Information List

Table 142. Porton Advanced Description and Business Overview

Table 143. Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 144. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Porton Advanced (2021–2026)

Table 145. Porton Advanced Recent Developments

Table 146. HanBio Basic Information List

Table 147. HanBio Description and Business Overview

Table 148. HanBio Adeno-Associated Virus (AAV) Packaging Service Products, Services, and Solutions

Table 149. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of HanBio (2021–2026)

Table 150. HanBio Recent Developments

Table 151. Revenue (US$ Million) in Adeno-Associated Virus (AAV) Packaging Service Business of Company 40 (2021–2026)

Table 152. Company 40 Recent Developments

Table 153. Key Raw Materials Lists

Table 154. Key Suppliers of Raw Materials Lists

Table 155. Adeno-Associated Virus (AAV) Packaging Service Downstream Customers

Table 156. Adeno-Associated Virus (AAV) Packaging Service Distributors List

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Adeno-Associated Virus (AAV) Packaging Service Product Picture

Figure 2. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 4. Adeno-Associated Virus (AAV) Packaging Service Report Years Considered

Figure 5. Global Adeno-Associated Virus (AAV) Packaging Service Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Adeno-Associated Virus (AAV) Packaging Service Revenue in 2025

Figure 7. Adeno-Associated Virus (AAV) Packaging Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Research Grade Picture

Figure 9. Preclinical Grade Picture

Figure 10. GMP Grade Picture

Figure 11. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value Market Share by Type, 2025 & 2032

Figure 13. Packaging Only Picture

Figure 14. Vector Construction and Packaging Picture

Figure 15. End-to-End Development and Manufacturing Picture

Figure 16. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Service Scope (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value Market Share by Service Scope, 2025 & 2032

Figure 18. Adherent HEK293 Picture

Figure 19. Suspension HEK293 Picture

Figure 20. Baculovirus-Sf9 Picture

Figure 21. Other Picture

Figure 22. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Production Platform (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value Market Share by Production Platform, 2025 & 2032

Figure 24. Product Picture of Academic and Research Institutions

Figure 25. Product Picture of Biotechnology Companies

Figure 26. Product Picture of Other

Figure 27. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global Adeno-Associated Virus (AAV) Packaging Service Sales Value Market Share by Application, 2025 & 2032

Figure 29. North America Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 30. North America Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

Figure 31. Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 32. Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

Figure 33. Asia Pacific Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 34. Asia Pacific Adeno-Associated Virus (AAV) Packaging Service Sales Value by Subregion (%), 2025 vs 2032

Figure 35. South America Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 36. South America Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

Figure 37. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 38. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (%), 2025 vs 2032

Figure 39. Key Countries/Regions Adeno-Associated Virus (AAV) Packaging Service Sales Value (%), 2021–2032

Figure 40. United States Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 41. United States Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

Figure 42. United States Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2025 vs 2032

Figure 43. Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 44. Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

Figure 45. Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2025 vs 2032

Figure 46. China Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 47. China Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

Figure 48. China Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2025 vs 2032

Figure 49. Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 50. Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

Figure 51. Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2025 vs 2032

Figure 52. South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 53. South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

Figure 54. South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2025 vs 2032

Figure 55. Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 56. Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

Figure 57. Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2025 vs 2032

Figure 58. India Adeno-Associated Virus (AAV) Packaging Service Sales Value (US$ Million), 2021–2032

Figure 59. India Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (%), 2025 vs 2032

Figure 60. India Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (%), 2025 vs 2032

Figure 61. Adeno-Associated Virus (AAV) Packaging Service Value Chain

Figure 62. Adeno-Associated Virus (AAV) Packaging Service Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Adeno-Associated Virus (AAV) Packaging Service market? zhanKai

The top companies in the global Adeno-Associated Virus (AAV) Packaging Service market are Thermo Fisher Scientific、Lonza、Charles River Laboratories.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Adeno-Associated Virus (AAV) Packaging Service market size from 2026 to 2032? shouQi

What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2026? shouQi

What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2032? shouQi

Related Reports

Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1249 million in 2025 to US$ 2627 million by 2032, at a CAGR of 11.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 161
USD 4900.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 149
USD 4250.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 144
USD 2900.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 107
USD 4250.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1390 million in 2024 to US$ 2488 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 147
USD 4900.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 122
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2025
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-03-12
Pages: 98
USD 2900.00
(Single User License)
Global and United States Adeno-Associated Virus (AAV) Packaging Service Market Report & Forecast 2024-2030
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 125
USD 4350.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 125
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Insights, Forecast to 2030
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published Date: 2025-01-01
Pages: 159
USD 4900.00
(Single User License)

Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1249 million in 2025 to US$ 2627 million by 2032, at a CAGR of 11.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 161
USD 4900.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 149
USD 4250.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.
Published: 2026-07-18
Pages: 144
USD 2900.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 107
USD 4250.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1390 million in 2024 to US$ 2488 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 147
USD 4900.00 (Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 122
USD 3950.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2025
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-03-12
Pages: 98
USD 2900.00 (Single User License)
Global and United States Adeno-Associated Virus (AAV) Packaging Service Market Report & Forecast 2024-2030
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published: 2025-01-01
Pages: 125
USD 4350.00 (Single User License)
Adeno-Associated Virus (AAV) Packaging Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 125
USD 3950.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Insights, Forecast to 2030
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published: 2025-01-01
Pages: 159
USD 4900.00 (Single User License)